In last trading session, ReShape Lifesciences Inc (NASDAQ:RSLS) saw 7.59 million shares changing hands with its beta currently measuring 1.49. Company’s recent per share price level of $0.38 trading at -$0.07 or -15.62% at ring of the bell on the day assigns it a market valuation of $1.25M. That closing price of RSLS’s stock is at a discount of -7531.58% from its 52-week high price of $29.00 and is indicating a premium of 10.53% from its 52-week low price of $0.34. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 34.24 million shares which gives us an average trading volume of 6.62 million if we extend that period to 3-months.

For ReShape Lifesciences Inc (RSLS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0 in the current quarter.

ReShape Lifesciences Inc (NASDAQ:RSLS) trade information

Upright in the red during last session for losing -15.62%, in the last five days RSLS remained trading in the red while hitting it’s week-highest on Tuesday, 04/01/25 when the stock touched $0.38 price level, adding 87.54% to its value on the day. ReShape Lifesciences Inc’s shares saw a change of -91.49% in year-to-date performance and have moved -13.80% in past 5-day. ReShape Lifesciences Inc (NASDAQ:RSLS) showed a performance of -61.65% in past 30-days. Number of shares sold short was 0.37 million shares which calculate 0.11 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 76.96% during past 5 years.

ReShape Lifesciences Inc (NASDAQ:RSLS)’s Major holders

Insiders are in possession of 14.01% of company’s total shares while institution are holding 16.64 percent of that, with stock having share float percentage of 19.35%. Investors also watch the number of corporate investors in a company very closely, which is 16.64% institutions for ReShape Lifesciences Inc that are currently holding shares of the company.